GE HealthCare (Nasdaq: GEHC) announced that it submitted its next-generation Signa Bolt MRI technology to the FDA for 510(k) ...
VIENNA--(BUSINESS WIRE)--Growing its range of magnetic resonance imaging (MRI) contrast media options available to patients and radiologists, GE Healthcare today announced the launch of Clariscan™ ...
GE Global Research and Mayo Clinic have received a five-year, $5.7 million grant from the National Institutes of Health (NIH) to jointly research a dedicated MRI brain scanner to image for a range of ...
Magnetic Resonance Imaging has come a long way in the three decades since its inception in GE research lab in upstate New York. In fact, the advancement in its capabilities over that time have been ...
CHALFONT ST GILES, England--(BUSINESS WIRE)--GE Healthcare has announced that it has received approval from the European Medicines Agency (EMA) for additional imaging modalities for its stress agent ...
Zacks Investment Research on MSN
GE HealthCare Unveils Next-Gen SIGNA MRI Systems to Elevate Efficiency
GE HealthCare GEHC recently unveiled its next-generation SIGNA MRI portfolio, the 3T SIGNA Bolt and 1.5T SIGNA Sprint with ...
The launch of Pixxoscan expands GE HealthCare’s portfolio of Magnetic Resonance Imaging (MRI) contrast agents, now offering two leading macrocyclic molecules to customers - Clariscan (gadoteric acid) ...
GE HealthCare (GEHC) announced the 510(k) submissions to the U.S. Food and Drug Administration, FDA, seeking clearance for next-generation SIGNA ...
US FDA approves +PLUSPAK™ (polymer bottle) Pharmacy Bulk Package for the gadolinium-based contrast agent, Clariscan™ (gadoterate meglumine) As the only polymer bottle for an MRI contrast agent, ...
CHICAGO, Jan 27 (Reuters) - Researchers at General Electric Co won a $3.27 million grant from the National Institutes of Health to develop a better magnet for MRI machines that will make them cheaper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback